[Vitaprost forte efficacy in patients with prostatic adenoma].
Efficacy and safety of a new bioregulatory peptide vitaprost forte was studied in 30 patients with prostatic adenoma. It is shown that this drug relieves clinical symptoms of the disease, improves quality of life, uroflowmetric parameters, reduces the size of the prostatic gland. Vitaprost forte is more effective in patients with prostatic adenoma combined with chronic prostatitis.
Tkachuk
V N
VN
Tkachuk
I N
IN
D000368:Aged; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D009929:Organ Size / Q000187:drug effects; D010455:Peptides / Q000008:administration & dosage*; D011467:Prostate / Q000473:pathology / Q000503:physiopathology; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D011472:Prostatitis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
D010455:Peptides; C524164:Vitaprost